Your browser doesn't support javascript.
loading
HLA-DR15 Molecules Jointly Shape an Autoreactive T Cell Repertoire in Multiple Sclerosis.
Wang, Jian; Jelcic, Ivan; Mühlenbruch, Lena; Haunerdinger, Veronika; Toussaint, Nora C; Zhao, Yingdong; Cruciani, Carolina; Faigle, Wolfgang; Naghavian, Reza; Foege, Magdalena; Binder, Thomas M C; Eiermann, Thomas; Opitz, Lennart; Fuentes-Font, Laura; Reynolds, Richard; Kwok, William W; Nguyen, Julie T; Lee, Jar-How; Lutterotti, Andreas; Münz, Christian; Rammensee, Hans-Georg; Hauri-Hohl, Mathias; Sospedra, Mireia; Stevanovic, Stefan; Martin, Roland.
Afiliación
  • Wang J; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Jelcic I; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Mühlenbruch L; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübin
  • Haunerdinger V; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich 8032, Switzerland.
  • Toussaint NC; NEXUS Personalized Health Technologies, ETH Zurich, Zurich 8093, Switzerland; Swiss Institute of Bioinformatics, Zurich, Switzerland.
  • Zhao Y; Biometric Research Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, MD 20850, USA.
  • Cruciani C; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Faigle W; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Naghavian R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Foege M; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Binder TMC; HLA Laboratory of the Stefan Morsch Foundation (SMS), Birkenfeld 55765, Germany.
  • Eiermann T; Department of Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg 20251, Germany.
  • Opitz L; Functional Genomics Center Zurich, Swiss Federal Institute of Technology and University of Zurich, Zurich 8057, Switzerland.
  • Fuentes-Font L; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.
  • Reynolds R; Division of Neuroscience, Department of Brain Sciences, Imperial College London, London, UK.
  • Kwok WW; Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.
  • Nguyen JT; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA.
  • Lee JH; One Lambda, Inc., a part of Transplant Diagnostics Thermo Fisher Scientific, 22801 Roscoe Blvd., West Hills, CA 91304, USA.
  • Lutterotti A; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Münz C; Viral Immunobiology, Institute of Experimental Immunology, University of Zurich, Zurich 8057, Switzerland.
  • Rammensee HG; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübin
  • Hauri-Hohl M; Pediatric Stem Cell Transplantation, University Children's Hospital Zurich, Zurich 8032, Switzerland.
  • Sospedra M; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland.
  • Stevanovic S; Department of Immunology, Institute of Cell Biology, University of Tübingen, Tübingen 72076, Germany; German Cancer Consortium (DKTK), Partner Site Tübingen, Tübingen 72076, Germany; Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies," University of Tübin
  • Martin R; Neuroimmunology and MS Research, Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich 8091, Switzerland. Electronic address: roland.martin@usz.ch.
Cell ; 183(5): 1264-1281.e20, 2020 11 25.
Article en En | MEDLINE | ID: mdl-33091337
ABSTRACT
The HLA-DR15 haplotype is the strongest genetic risk factor for multiple sclerosis (MS), but our understanding of how it contributes to MS is limited. Because autoreactive CD4+ T cells and B cells as antigen-presenting cells are involved in MS pathogenesis, we characterized the immunopeptidomes of the two HLA-DR15 allomorphs DR2a and DR2b of human primary B cells and monocytes, thymus, and MS brain tissue. Self-peptides from HLA-DR molecules, particularly from DR2a and DR2b themselves, are abundant on B cells and thymic antigen-presenting cells. Furthermore, we identified autoreactive CD4+ T cell clones that can cross-react with HLA-DR-derived self-peptides (HLA-DR-SPs), peptides from MS-associated foreign agents (Epstein-Barr virus and Akkermansia muciniphila), and autoantigens presented by DR2a and DR2b. Thus, both HLA-DR15 allomorphs jointly shape an autoreactive T cell repertoire by serving as antigen-presenting structures and epitope sources and by presenting the same foreign peptides and autoantigens to autoreactive CD4+ T cells in MS.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Subtipos Serológicos HLA-DR / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Año: 2020 Tipo del documento: Article País de afiliación: Suiza

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Subtipos Serológicos HLA-DR / Esclerosis Múltiple Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Año: 2020 Tipo del documento: Article País de afiliación: Suiza